Sphera Funds Management LTD Trimmed Caesarstone LTD (CSTE) Stake By $3.04 Million; Oracle (ORCL) Shorts Raised By 18.8%

March 17, 2018 - By Adrian Mccoy

Oracle Corporation (NYSE:ORCL) had an increase of 18.8% in short interest. ORCL’s SI was 40.29M shares in March as released by FINRA. Its up 18.8% from 33.91 million shares previously. With 16.20M avg volume, 3 days are for Oracle Corporation (NYSE:ORCL)’s short sellers to cover ORCL’s short positions. The SI to Oracle Corporation’s float is 1.34%. The stock decreased 0.19% or $0.1 during the last trading session, reaching $52.27. About 21.01M shares traded or 35.25% up from the average. Oracle Corporation (NYSE:ORCL) has risen 14.08% since March 17, 2017 and is uptrending. It has underperformed by 2.62% the S&P500.

Sphera Funds Management Ltd decreased Caesarstone Ltd (CSTE) stake by 85.48% reported in 2017Q3 SEC filing. Sphera Funds Management Ltd sold 104,964 shares as Caesarstone Ltd (CSTE)’s stock rose 15.69%. The Sphera Funds Management Ltd holds 17,833 shares with $531,000 value, down from 122,797 last quarter. Caesarstone Ltd now has $685.06M valuation. The stock decreased 1.48% or $0.3 during the last trading session, reaching $19.95. About 208,971 shares traded. Caesarstone Ltd. (NASDAQ:CSTE) has risen 6.39% since March 17, 2017 and is uptrending. It has underperformed by 10.31% the S&P500.

Sphera Funds Management Ltd increased Vistagen Therapeutics Inc (VSTA) stake by 514,286 shares to 1.06M valued at $1.69M in 2017Q3. It also upped Eiger Biopharmaceuticals Inc stake by 134,968 shares and now owns 520,269 shares. La Jolla Pharmaceutical Co (NASDAQ:LJPC) was raised too.

Among 10 analysts covering Caesarstone Sdot-Yam (NASDAQ:CSTE), 3 have Buy rating, 3 Sell and 4 Hold. Therefore 30% are positive. Caesarstone Sdot-Yam had 28 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Caesarstone Ltd. (NASDAQ:CSTE) earned “Neutral” rating by Bank of America on Thursday, August 6. The firm earned “Buy” rating on Monday, November 7 by Chardan Capital Markets. The company was downgraded on Thursday, November 3 by Stifel Nicolaus. The rating was upgraded by Credit Suisse on Wednesday, February 7 to “Hold”. The stock has “Equal-Weight” rating by Barclays Capital on Thursday, February 11. Chardan Capital Markets maintained the shares of CSTE in report on Tuesday, November 7 with “Hold” rating. The stock has “Buy” rating by Stifel Nicolaus on Thursday, October 29. On Wednesday, April 6 the stock rating was initiated by Chardan Capital Markets with “Buy”. As per Friday, October 16, the company rating was upgraded by Bank of America. As per Tuesday, October 13, the company rating was maintained by Barclays Capital.

Analysts await Caesarstone Ltd. (NASDAQ:CSTE) to report earnings on May, 9. They expect $0.18 EPS, down 41.94% or $0.13 from last year’s $0.31 per share. CSTE’s profit will be $6.18M for 27.71 P/E if the $0.18 EPS becomes a reality. After $0.19 actual EPS reported by Caesarstone Ltd. for the previous quarter, Wall Street now forecasts -5.26% negative EPS growth.

Oracle Corporation develops, manufactures, markets, sells, hosts, and supports application, platform, and infrastructure technologies for information technology environments worldwide. The company has market cap of $216.38 billion. It provides services in three primary layers of the cloud: Software as a Service, Platform as a Service, and Infrastructure as a Service. It has a 22.45 P/E ratio. The firm licenses its Oracle Database software, which enables storage, retrieval, and manipulation of data; and Oracle Fusion Middleware software to build, deploy, secure, access, and integrate business applications, as well as automate their business processes.

Among 38 analysts covering Oracle (NYSE:ORCL), 28 have Buy rating, 0 Sell and 10 Hold. Therefore 74% are positive. Oracle had 107 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was downgraded by JMP Securities to “Mkt Perform” on Wednesday, October 14. The stock has “Overweight” rating by Barclays Capital on Monday, March 12. The stock has “Buy” rating by Cowen & Co on Monday, September 11. The stock of Oracle Corporation (NYSE:ORCL) has “Overweight” rating given on Friday, September 15 by Barclays Capital. UBS maintained it with “Buy” rating and $57.0 target in Friday, September 15 report. The rating was maintained by Wunderlich with “Hold” on Friday, June 17. Stifel Nicolaus maintained the shares of ORCL in report on Monday, July 24 with “Buy” rating. BMO Capital Markets maintained the stock with “Outperform” rating in Thursday, March 16 report. As per Thursday, March 30, the company rating was maintained by Wedbush. Citigroup maintained the stock with “Neutral” rating in Friday, June 17 report.

Investors sentiment increased to 1.15 in 2017 Q3. Its up 0.02, from 1.13 in 2017Q2. It increased, as 67 investors sold Oracle Corporation shares while 498 reduced holdings. 122 funds opened positions while 519 raised stakes. 2.32 billion shares or 1.54% less from 2.35 billion shares in 2017Q2 were reported. St Johns Inv Mgmt Ltd Liability Co reported 0.68% in Oracle Corporation (NYSE:ORCL). Oxbow Advsr Ltd Liability Corp, a Texas-based fund reported 48,325 shares. Guardian Cap L P stated it has 30,846 shares. Clark Capital Management Gp invested in 59,509 shares or 0.1% of the stock. Hellman Jordan Mngmt Com Ma has invested 2.86% in Oracle Corporation (NYSE:ORCL). Smith Moore Co accumulated 0.15% or 11,044 shares. Manning Napier Advisors Limited Liability, a New York-based fund reported 78,565 shares. Fdx Advsrs accumulated 114,359 shares. Stephens Ar stated it has 166,354 shares. Ariel Invs Llc stated it has 0.11% of its portfolio in Oracle Corporation (NYSE:ORCL). Ibm Retirement Fund has invested 0.7% in Oracle Corporation (NYSE:ORCL). Pinnacle Fincl Prtnrs stated it has 0.65% of its portfolio in Oracle Corporation (NYSE:ORCL). Longer invested in 1.76% or 40,850 shares. Menora Mivtachim Limited owns 906,690 shares. Hartline Inv Corporation reported 5,618 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: